Cinek T, Sadra A, Imboden J B
Department of Medicine, Rosalind Russell Research Laboratory, San Francisco General Hospital, CA 94143, USA.
J Immunol. 2000 Jan 1;164(1):5-8. doi: 10.4049/jimmunol.164.1.5.
CTLA-4 is an important inhibitor of T cell activation. We used Jurkat cells expressing mutants of murine CTLA-4 to study the structural requirements for inhibitory signaling. We find that signals for the inhibition of IL-2 secretion are delivered efficiently by a CTLA-4 mutant in which both cytoplasmic tyrosines have been replaced by phenylalanines. A CTLA-4 mutant that lacks the carboxyl-terminal half of the intracellular domain also retains the ability to inhibit, but deletion of an additional 11 aa completely abrogates that capability. We conclude that delivery of an inhibitory signal requires the membrane-proximal region of the CTLA-4 cytoplasmic domain and does not depend upon the tyrosine phosphorylation of CTLA-4.
细胞毒性T淋巴细胞相关抗原4(CTLA-4)是T细胞活化的重要抑制剂。我们使用表达小鼠CTLA-4突变体的Jurkat细胞来研究抑制性信号传导的结构要求。我们发现,一种CTLA-4突变体可有效传递抑制白细胞介素-2分泌的信号,该突变体的两个胞质酪氨酸均已被苯丙氨酸取代。一种缺乏细胞内结构域羧基末端一半的CTLA-4突变体也保留了抑制能力,但再缺失另外11个氨基酸则完全消除了该能力。我们得出结论,抑制性信号的传递需要CTLA-4胞质结构域的膜近端区域,且不依赖于CTLA-4的酪氨酸磷酸化。